PT2338508T - Vírus da dengue quimérico recombinante rden3/4delta30(me), rden2/4delta30(me) ou rden1/4delta30(me) contendo uma deleção de 30 nucleótidos (delta30) numa secção da região não traduzida a 3¿ do genoma da dengue de tipo 4, em que a referida deleção de 30 nucleótidos corresponde à estrutura em gancho de cabelo tl2 - Google Patents
Vírus da dengue quimérico recombinante rden3/4delta30(me), rden2/4delta30(me) ou rden1/4delta30(me) contendo uma deleção de 30 nucleótidos (delta30) numa secção da região não traduzida a 3¿ do genoma da dengue de tipo 4, em que a referida deleção de 30 nucleótidos corresponde à estrutura em gancho de cabelo tl2Info
- Publication number
- PT2338508T PT2338508T PT101777357T PT10177735T PT2338508T PT 2338508 T PT2338508 T PT 2338508T PT 101777357 T PT101777357 T PT 101777357T PT 10177735 T PT10177735 T PT 10177735T PT 2338508 T PT2338508 T PT 2338508T
- Authority
- PT
- Portugal
- Prior art keywords
- 4delta30
- nucleotide deletion
- genome
- 4delta
- delta30
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37786002P | 2002-05-03 | 2002-05-03 | |
US43650002P | 2002-12-23 | 2002-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2338508T true PT2338508T (pt) | 2018-05-16 |
Family
ID=29406814
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03724319T PT1554301E (pt) | 2002-05-03 | 2003-04-25 | Vacina tetravalente contra a dengue contendo uma deleção comum de 30 nucleótidos na 3¿-utr da dengue de tipos 1, 2, 3 e 4 ou vírus quiméricos antigénicos da dengue 1, 2, 3 e 4 |
PT101777357T PT2338508T (pt) | 2002-05-03 | 2003-04-25 | Vírus da dengue quimérico recombinante rden3/4delta30(me), rden2/4delta30(me) ou rden1/4delta30(me) contendo uma deleção de 30 nucleótidos (delta30) numa secção da região não traduzida a 3¿ do genoma da dengue de tipo 4, em que a referida deleção de 30 nucleótidos corresponde à estrutura em gancho de cabelo tl2 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03724319T PT1554301E (pt) | 2002-05-03 | 2003-04-25 | Vacina tetravalente contra a dengue contendo uma deleção comum de 30 nucleótidos na 3¿-utr da dengue de tipos 1, 2, 3 e 4 ou vírus quiméricos antigénicos da dengue 1, 2, 3 e 4 |
Country Status (15)
Country | Link |
---|---|
US (7) | US7517531B2 (pt) |
EP (5) | EP2319532A1 (pt) |
JP (1) | JP4977811B2 (pt) |
AT (1) | ATE481982T1 (pt) |
BR (1) | BRPI0309631B1 (pt) |
CA (1) | CA2483653C (pt) |
CY (1) | CY1120558T1 (pt) |
DE (1) | DE60334310D1 (pt) |
DK (2) | DK2338508T3 (pt) |
ES (2) | ES2355719T3 (pt) |
HU (1) | HUE037330T2 (pt) |
PT (2) | PT1554301E (pt) |
SI (2) | SI2338508T1 (pt) |
TR (1) | TR201806655T4 (pt) |
WO (1) | WO2003092592A2 (pt) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60334310D1 (de) * | 2002-05-03 | 2010-11-04 | Us Gov Health & Human Serv | Dengue-vakzine mit einer gemeinsamen 30 nukleotid-deletion im 3'-utr der dengue-typen 1 und 2. |
CA2605924A1 (en) | 2005-04-24 | 2006-11-02 | Acambis Inc. | Recombinant flavivirus vaccines |
JP4549224B2 (ja) * | 2005-04-25 | 2010-09-22 | 出光ユニテック株式会社 | 透明ポリプロピレン系樹脂シートの製造方法、透明ポリプロピレン系樹脂シート、及び成形品、並びに透明ポリプロピレン系樹脂シートからなる成形品の白化防止方法、及び温度判別方法 |
EP1893637B1 (en) * | 2005-06-17 | 2016-01-06 | Sanofi Pasteur | Dengue serotype 1 attenuated strain |
JP5075120B2 (ja) | 2005-06-17 | 2012-11-14 | サノフィ・パスツール | デング熱セロタイプ2の弱毒化株 |
WO2007015783A2 (en) * | 2005-07-22 | 2007-02-08 | Research Development Foundation | Attenuated strains of flaviviruses , and uses thereof |
AU2016219680B2 (en) * | 2006-08-15 | 2018-08-09 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | Development of dengue virus vaccine components |
AU2013263788B2 (en) * | 2006-08-15 | 2016-05-26 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | Development of dengue virus vaccine components |
ES2585553T3 (es) | 2006-08-15 | 2016-10-06 | The Government Of The U.S.A., As Repr. By The Secretary, Dept. Of Health & Human Services, The Nat. Inst. Of Health | Desarrollo de componentes de vacunas del virus del dengue |
JP5623786B2 (ja) | 2009-05-22 | 2014-11-12 | 三星ディスプレイ株式會社Samsung Display Co.,Ltd. | 薄膜蒸着装置 |
JP5620146B2 (ja) | 2009-05-22 | 2014-11-05 | 三星ディスプレイ株式會社Samsung Display Co.,Ltd. | 薄膜蒸着装置 |
KR101117719B1 (ko) * | 2009-06-24 | 2012-03-08 | 삼성모바일디스플레이주식회사 | 박막 증착 장치 |
JP5328726B2 (ja) | 2009-08-25 | 2013-10-30 | 三星ディスプレイ株式會社 | 薄膜蒸着装置及びこれを利用した有機発光ディスプレイ装置の製造方法 |
JP5677785B2 (ja) | 2009-08-27 | 2015-02-25 | 三星ディスプレイ株式會社Samsung Display Co.,Ltd. | 薄膜蒸着装置及びこれを利用した有機発光表示装置の製造方法 |
JP6057460B2 (ja) * | 2009-08-31 | 2017-01-11 | ジェン−プローブ・インコーポレーテッド | デングウイルスアッセイ |
US8876975B2 (en) | 2009-10-19 | 2014-11-04 | Samsung Display Co., Ltd. | Thin film deposition apparatus |
KR101084184B1 (ko) | 2010-01-11 | 2011-11-17 | 삼성모바일디스플레이주식회사 | 박막 증착 장치 |
KR101174875B1 (ko) | 2010-01-14 | 2012-08-17 | 삼성디스플레이 주식회사 | 박막 증착 장치, 이를 이용한 유기 발광 디스플레이 장치의 제조방법 및 이에 따라 제조된 유기 발광 디스플레이 장치 |
KR101193186B1 (ko) | 2010-02-01 | 2012-10-19 | 삼성디스플레이 주식회사 | 박막 증착 장치, 이를 이용한 유기 발광 디스플레이 장치의 제조방법 및 이에 따라 제조된 유기 발광 디스플레이 장치 |
KR101156441B1 (ko) | 2010-03-11 | 2012-06-18 | 삼성모바일디스플레이주식회사 | 박막 증착 장치 |
KR101202348B1 (ko) | 2010-04-06 | 2012-11-16 | 삼성디스플레이 주식회사 | 박막 증착 장치 및 이를 이용한 유기 발광 표시 장치의 제조 방법 |
US8894458B2 (en) | 2010-04-28 | 2014-11-25 | Samsung Display Co., Ltd. | Thin film deposition apparatus, method of manufacturing organic light-emitting display device by using the apparatus, and organic light-emitting display device manufactured by using the method |
IT1400574B1 (it) | 2010-05-06 | 2013-06-14 | Freni Brembo Spa | Dispositivo di frenatura a disco per veicoli |
US8685649B2 (en) * | 2010-06-10 | 2014-04-01 | The United States Of America As Represented By The Secretary Of The Navy | RT-LAMP assay for the detection of pan-serotype dengue virus |
KR101223723B1 (ko) | 2010-07-07 | 2013-01-18 | 삼성디스플레이 주식회사 | 박막 증착 장치, 이를 이용한 유기 발광 디스플레이 장치의 제조방법 및 이에 따라 제조된 유기 발광 디스플레이 장치 |
WO2012045063A2 (en) * | 2010-10-01 | 2012-04-05 | University Of Rochester | Flavivirus domain iii vaccine |
KR101723506B1 (ko) | 2010-10-22 | 2017-04-19 | 삼성디스플레이 주식회사 | 유기층 증착 장치 및 이를 이용한 유기 발광 디스플레이 장치의 제조 방법 |
KR101738531B1 (ko) | 2010-10-22 | 2017-05-23 | 삼성디스플레이 주식회사 | 유기 발광 디스플레이 장치의 제조 방법 및 이에 따라 제조된 유기 발광 디스플레이 장치 |
KR20120045865A (ko) | 2010-11-01 | 2012-05-09 | 삼성모바일디스플레이주식회사 | 유기층 증착 장치 |
US20120294889A1 (en) * | 2010-11-12 | 2012-11-22 | Paxvax, Inc. | Chimeric Flavivirus Vaccines |
KR20120065789A (ko) | 2010-12-13 | 2012-06-21 | 삼성모바일디스플레이주식회사 | 유기층 증착 장치 |
KR101760897B1 (ko) | 2011-01-12 | 2017-07-25 | 삼성디스플레이 주식회사 | 증착원 및 이를 구비하는 유기막 증착 장치 |
KR101852517B1 (ko) | 2011-05-25 | 2018-04-27 | 삼성디스플레이 주식회사 | 유기층 증착 장치 및 이를 이용한 유기 발광 디스플레이 장치의 제조 방법 |
KR101840654B1 (ko) | 2011-05-25 | 2018-03-22 | 삼성디스플레이 주식회사 | 유기층 증착 장치 및 이를 이용한 유기 발광 디스플레이 장치의 제조 방법 |
KR101857249B1 (ko) | 2011-05-27 | 2018-05-14 | 삼성디스플레이 주식회사 | 패터닝 슬릿 시트 어셈블리, 유기막 증착 장치, 유기 발광 표시장치제조 방법 및 유기 발광 표시 장치 |
KR101826068B1 (ko) | 2011-07-04 | 2018-02-07 | 삼성디스플레이 주식회사 | 유기층 증착 장치 |
KR20130004830A (ko) | 2011-07-04 | 2013-01-14 | 삼성디스플레이 주식회사 | 유기층 증착 장치 및 이를 이용한 유기 발광 표시 장치의 제조 방법 |
KR102015872B1 (ko) | 2012-06-22 | 2019-10-22 | 삼성디스플레이 주식회사 | 유기층 증착 장치, 이를 이용한 유기 발광 디스플레이 장치의 제조 방법 및 이에 따라 제조된 유기 발광 디스플레이 장치 |
US8895028B2 (en) | 2012-07-20 | 2014-11-25 | Arbovax, Inc. | Methods and compositions for dengue virus 3 (DV3) infectious clone |
KR20150036593A (ko) * | 2012-07-24 | 2015-04-07 | 사노피 파스퇴르 | 뎅기열 바이러스 감염 예방용 백신 조성물 |
KR102081284B1 (ko) | 2013-04-18 | 2020-02-26 | 삼성디스플레이 주식회사 | 증착장치, 이를 이용한 유기발광 디스플레이 장치 제조 방법 및 유기발광 디스플레이 장치 |
US9861692B2 (en) | 2013-06-21 | 2018-01-09 | Merck Sharp & Dohme Corp. | Dengue virus vaccine compositions and methods of use thereof |
NO340722B1 (no) * | 2014-06-27 | 2017-06-06 | Norwegian Institute For Agricultural & Environmental Res | Transgene planter som uttrykker et rekombinant tetravalent kimært denguevirusantigen for å fremstille effektive vaksiner avledet derfra, samt transgent plastid, plantecelle og frø, rekombinant DNA molekyl, vektor, fremgangsmåter for fremstilling og anvendelse derav |
BR112017013270A2 (pt) | 2014-12-22 | 2018-03-06 | Merck Sharp & Dohme | ?composição de vacina contra vírus da dengue, métodos para induzir uma resposta imune contra dengue, para reduzir a probabilidade de infecção por dengue, ou prevenir ou atenuar os sintomas da mesma, e, uso de uma composição de vacina contra vírus da dengue?. |
US10004795B2 (en) * | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
US11285202B2 (en) * | 2016-01-26 | 2022-03-29 | University Of South Carolina | Polymer-protein core-shell particles as effective vaccine delivery vehicles and treatments methods using the same |
WO2017156511A1 (en) | 2016-03-11 | 2017-09-14 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Live attenuated zika virus vaccine |
CN109069615A (zh) * | 2016-04-13 | 2018-12-21 | 武田疫苗股份有限公司 | 在儿童和年轻人中针对登革热病毒接种疫苗的组合物和方法 |
WO2018129160A1 (en) | 2017-01-06 | 2018-07-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Live attenuated flavivirus vaccines and methods of using and making same |
CA3083772A1 (en) | 2017-12-07 | 2019-06-13 | Merck Sharp & Dohme Corp. | Formulations of dengue virus vaccine compositions |
EP3846848A4 (en) * | 2018-09-04 | 2022-07-06 | The Board of Regents of the University of Texas System | DNA PLASMID INITIATED LIVE VACCINES FOR PLUS-POLARITY SINGLE STRAND RNA VIRUS |
WO2021173597A1 (en) * | 2020-02-28 | 2021-09-02 | Merck Sharp & Dohme Corp. | Dengue serotype specific rt-pcr multiplex assay |
WO2023161715A1 (en) * | 2022-02-22 | 2023-08-31 | Futr Bio Ltda. | Next generation mrna vaccines |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2365415A1 (en) * | 1999-03-26 | 2000-10-05 | Bruce L. Innis | Adaptation of virus to vertebrate cells |
EP1159969A1 (fr) * | 2000-05-30 | 2001-12-05 | Aventis Pasteur | Vaccine composition |
DK2292802T3 (en) | 2001-05-22 | 2015-03-09 | Us Gov Health & Human Serv | Development of mutations useful for attenuation of dengue viruses and chimeric dengue viruses |
DE60334310D1 (de) * | 2002-05-03 | 2010-11-04 | Us Gov Health & Human Serv | Dengue-vakzine mit einer gemeinsamen 30 nukleotid-deletion im 3'-utr der dengue-typen 1 und 2. |
ES2585553T3 (es) * | 2006-08-15 | 2016-10-06 | The Government Of The U.S.A., As Repr. By The Secretary, Dept. Of Health & Human Services, The Nat. Inst. Of Health | Desarrollo de componentes de vacunas del virus del dengue |
-
2003
- 2003-04-25 DE DE60334310T patent/DE60334310D1/de not_active Expired - Lifetime
- 2003-04-25 PT PT03724319T patent/PT1554301E/pt unknown
- 2003-04-25 ES ES03724319T patent/ES2355719T3/es not_active Expired - Lifetime
- 2003-04-25 CA CA2483653A patent/CA2483653C/en not_active Expired - Lifetime
- 2003-04-25 WO PCT/US2003/013279 patent/WO2003092592A2/en active Application Filing
- 2003-04-25 DK DK10177735.7T patent/DK2338508T3/en active
- 2003-04-25 EP EP10177740A patent/EP2319532A1/en not_active Ceased
- 2003-04-25 EP EP20153909.5A patent/EP3763382A1/en active Pending
- 2003-04-25 EP EP10177735.7A patent/EP2338508B1/en not_active Expired - Lifetime
- 2003-04-25 PT PT101777357T patent/PT2338508T/pt unknown
- 2003-04-25 JP JP2004500777A patent/JP4977811B2/ja not_active Expired - Lifetime
- 2003-04-25 DK DK03724319.3T patent/DK1554301T3/da active
- 2003-04-25 TR TR2018/06655T patent/TR201806655T4/tr unknown
- 2003-04-25 AT AT03724319T patent/ATE481982T1/de active
- 2003-04-25 EP EP03724319A patent/EP1554301B1/en not_active Expired - Lifetime
- 2003-04-25 SI SI200332569T patent/SI2338508T1/en unknown
- 2003-04-25 HU HUE10177735A patent/HUE037330T2/hu unknown
- 2003-04-25 ES ES10177735.7T patent/ES2677348T3/es not_active Expired - Lifetime
- 2003-04-25 EP EP17155603.8A patent/EP3205352A1/en not_active Withdrawn
- 2003-04-25 SI SI200331929T patent/SI1554301T1/sl unknown
- 2003-04-25 BR BRPI0309631-9A patent/BRPI0309631B1/pt not_active IP Right Cessation
-
2004
- 2004-10-21 US US10/970,640 patent/US7517531B2/en not_active Ceased
-
2009
- 2009-03-04 US US12/398,043 patent/US8075903B2/en not_active Ceased
-
2011
- 2011-11-28 US US13/305,639 patent/US9783787B2/en not_active Expired - Lifetime
-
2013
- 2013-05-17 US US13/896,388 patent/USRE46641E1/en not_active Expired - Lifetime
- 2013-05-17 US US13/896,384 patent/USRE46631E1/en active Active
-
2017
- 2017-09-20 US US15/710,672 patent/US10837003B2/en not_active Expired - Lifetime
-
2018
- 2018-05-14 CY CY20181100488T patent/CY1120558T1/el unknown
-
2020
- 2020-09-01 US US17/009,448 patent/US11753627B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2338508T (pt) | Vírus da dengue quimérico recombinante rden3/4delta30(me), rden2/4delta30(me) ou rden1/4delta30(me) contendo uma deleção de 30 nucleótidos (delta30) numa secção da região não traduzida a 3¿ do genoma da dengue de tipo 4, em que a referida deleção de 30 nucleótidos corresponde à estrutura em gancho de cabelo tl2 | |
ZA200007403B (en) | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals. | |
ATE468858T1 (de) | Chimäre impfstoffe gegen flaviviren | |
UA85536C2 (en) | Viral antigens | |
AP1771A (en) | 3'-Prodrugs of 2'-deoxy-?-L-nucleosides. | |
WO2009039248A3 (en) | Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection | |
ATE197607T1 (de) | Chimäre und/oder wachstumgehemmte flaviviren | |
WO2003023040A3 (en) | Vaccinia virus mva-e3l-knockout-mutants and use thereof | |
WO2002072803A3 (en) | Subgenomic replicons of the flavivirus dengue | |
SI1404852T1 (sl) | Ekspresija genov v modularnem vakcinija virusa Ankara z uporabo ATI promotorja kravjih ospic | |
WO2003037265A3 (en) | Method of treating viral infections | |
AU5460900A (en) | Infectious cdna clone of gb virus b and uses thereof | |
WO1999057284A3 (en) | Attenuated influenza viruses | |
DE60330795D1 (de) | Impfstoff gegen west nile virus | |
NZ511168A (en) | Recombinant CELO virus and CELO virus DNA | |
WO2002083896A3 (en) | Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same | |
ATE263234T1 (de) | Veränderte, kleine rna-viren | |
CY1117369T1 (el) | Εμβολιο για τον δαγγειο πυρετο που περιεχει μια κοινη 30 νουκλεοτιδιων διαγραφη στην 3'-utr των τυπων 1 και 2 ιου του δαγγειου πυρετου | |
IL158739A0 (en) | Anti-virus agent | |
谢迎秋 et al. | Regulatory effect of cotton leaf curl virus AC2 on virion sense promoter | |
MY145463A (en) | Flavivirus ns1 subunit vaccine |